𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The sensitivity of head and neck squamous cell carcinomas to tumor necrosis factor-α

✍ Scribed by Izumi Mochimatsu; Mamoru Tsukuda; Shigeru Furukawa; Satoko Watanabe; Akira Kubota; Shunsuke Yanoma

Publisher
Springer
Year
1993
Tongue
English
Weight
418 KB
Volume
6
Category
Article
ISSN
0921-299X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Galectins as modulators of tumor progres
Galectins as modulators of tumor progression in head and neck squamous cell carcinomas
✍ Sven Saussez; Isabelle Camby; Gerard Toubeau; Robert Kiss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

## Abstract Head and neck squamous cell carcinomas (HNSCCs) remain a significant cause of morbidity worldwide. Biological therapies able to induce and/or upregulate antitumor immune responses could represent a complementary approach to conventional treatments for patients with HNSCC because, despit

Tumor angiogenesis and prognosis in squa
Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck
✍ Dr. Ulf K. Zätterström; Dr. Eva Brun; Dr. Roger Willén; Dr. Elisabeth Kjellén; D 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Background. The progression of tumor growth requires the recruitment of new blood vessels. It has been suggested that the degree of neovascularization would correlate with clinical prognosis. The purpose of the present study was to ascertain whether tumor vascularization correlated with clinical out

DNA alterations in tumor scrapes vs. bio
DNA alterations in tumor scrapes vs. biopsies of squamous-cell carcinomas of the head and neck
✍ Carol L. Rosenberg; Erin M. Finnemore; Pamela S. Larson; Christine P. Nogueira; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB 👁 2 views

Genetic abnormalities in SCCHNs are frequent and may be useful for screening, follow-up and prognosis. A biopsy or resection generally is utilized to identify these alterations but analysis of scraped or exfoliated tumor cells has been proposed as simpler and more versatile. It is unknown how well g

Time to recurrence of squamous cell carc
Time to recurrence of squamous cell carcinoma of the head and neck
✍ Professor Philip M. Stell 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

A personal series of 3,215 patients with proven squamous cell carcinoma of the mucosal surfaces of the upper aerodigestive tract is presented. Of these patients, 515 suffered a recurrence of their primary tumor after a course of radiotherapy. The time from the end of radiotherapy to diagnosis of a p

Butyrate response factor 1 enhances cisp
Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines
✍ Seung Koo Lee; Seong Bum Kim; Jong Soo Kim; Chang Hoon Moon; Myung Shin Han; Byu 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

Cisplatin is a widely used chemotherapeutic agent in head and neck squamous cell carcinoma (HNSCC). Resistance to cisplatin is a common feature of HNSCC. To identify genes that may regulate cisplatin sensitivity, we carried out a cDNA microarray analysis of gene expression in cisplatin-sensitive and